IDEXX Laboratories, Inc. · NASDAQ:IDXX

Mazelsky Jonathan Jay sold 25,140 IDEXX Laboratories, Inc. shares (Form 4)

Traded Nov 4, 2026 · Filed Nov 5, 2026

On Nov 4, 2026, Mazelsky Jonathan Jay (Director, Executive Chair of the Board) sold 25,140 IDEXX Laboratories, Inc. shares at an average US$703.19 for US$17.7M, leaving 83,803 shares. Filed Nov 5, 2026 (Form 4).

Sold
25,140 shares
Price
US$703.19 average (US$698.26 to US$711.95)
Value
US$17.7M
Holding after
83,803 shares
Trading plan
No
Role
Director, Executive Chair of the Board

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 4, 2026Common StockOption exercise25,140US$178.26108,943Direct
Nov 4, 2026Common StockSale1,945US$698.26106,998Direct
Nov 4, 2026Common StockSale4,075US$699.33102,923Direct
Nov 4, 2026Common StockSale1,667US$700.33101,256Direct
Nov 4, 2026Common StockSale4,540US$701.3696,716Direct
Nov 4, 2026Common StockSale2,136US$702.2194,580Direct
Nov 4, 2026Common StockSale3,950US$703.4590,630Direct
Nov 4, 2026Common StockSale240US$705.5990,390Direct
Nov 4, 2026Common StockSale840US$707.0089,550Direct
Nov 4, 2026Common StockSale1,840US$707.8487,710Direct
Nov 4, 2026Common StockSale1,300US$709.0086,410Direct
Nov 4, 2026Common StockSale1,501US$710.1284,909Direct
Nov 4, 2026Common StockSale775US$711.3184,134Direct
Nov 4, 2026Common StockSale331US$711.9583,803Direct

Source

Download original · View original at SEC

Related